Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Betamethasone and Ropivacaine Block for Post-thoracotomy Pain
NCT05556122Unknown
- Sponsor
- Affiliated Hospital of Nantong University
- Start
- Jul 2022
- Primary completion
- Dec 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, single-blind trial of ropivacaine and compound betamethasone in post-thoracotomy pain syndrome (PTPS) (2 arms), sponsored by Affiliated Hospital of Nantong University. Primary endpoint: Acute and chronic postoperative pain at 3 months. Status: unknown.
02
Drugs
ropivacainecompound betamethasone
03
Conditions
post-thoracotomy pain syndrome (PTPS)
Beyond the preview
Go deeper on NCT05556122.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05556122.